Pharmadax Inc. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was TWD 566.32 million compared to TWD 154.8 million a year ago. Net income was TWD 98.74 million compared to net loss of TWD 167.32 million a year ago.

Basic earnings per share from continuing operations was TWD 1.27 compared to basic loss per share from continuing operations of TWD 2.36 a year ago. Diluted earnings per share from continuing operations was TWD 1.27 compared to diluted loss per share from continuing operations of TWD 2.36 a year ago.